1. SAFE MEDICINE DISPOSAL FOR ME *** A way for Maine’s citizens to safely and properly get rid of unused or expired medicine Funded by the U.S. EPA (Grant #CH-83336001-0)

2. Presentation Outline  History of the Safe Medicine Disposal for ME Program and its development  Overview of program model and participant instructions  Preliminary phase I data review  Phase II and program expansion

3. Why Maine?: The State’s Prescription Drug Problem  In 2007, nearly 90% of Maine drug deaths were caused by prescription drugs  Maine Drug Enforcement Agency arrests for prescription drug misuse or diversion has increased dramatically to 23% of all arrests  In terms of the relationship of pharmaceuticals to violent crime and property crime, Maine ranks number one in the country  Maine ranks second in terms of the availability of pharmaceuticals for abuse

4.  Large rural regions  38th in population density; < 10 residents per square mile in over half of state Distribution/collection and financial challenges Distribution/collection and financial challenges Chronic illness and related drug use higher in rural areas Chronic illness and related drug use higher in rural areas  Oldest state Median age 41.2 years (United States Census, 2005) Median age 41.2 years (United States Census, 2005) Americans 65+ account for over 1/3 of prescriptions dispensed, but only 13% of the national population Americans 65+ account for over 1/3 of prescriptions dispensed, but only 13% of the national population Why Maine? The Challenges of a Rural and Aging State

5.  It curtails childhood overdoses  It restricts household drug theft  It limits accumulation of drugs by the elderly and other high users  It protects our physical environment  It restrains improper drug donations  It eliminates waste in the health care system Drug Collection Benefits

6. Coalition Building  Began with Maine Benzodiazepine Study Group and Maine Drug Enforcement Agency  Convened a group stakeholders from children’s advocacy, environmental organizations, medical associations, and others to create legislative solution

7.  Public Law 2003, Chapter 679 Maine Unused Pharmaceutical Disposal Program Maine Unused Pharmaceutical Disposal Program Program administration – Maine Drug Enforcement Agency Program administration – Maine Drug Enforcement Agency Maine Drug Return Implementation Group Maine Drug Return Implementation Group  LD 411 “An Act To Establish a Pilot Program for Return of Unused Prescription Drugs by Mail” (Sponsored by Representative Anne Perry) (Signed 6/27/07) Historic State Legislation

8. Proper Drug Disposal Day Proclamation  First proclamation in the nation on safe drug disposal endorsed by a governor  Signed by Maine’s governor on October 31, 2007  Recognizes the negative impact to public health and the environment of unwanted consumer pharmaceuticals  Recognizes the lack of effective and efficient methods of drug disposal has resulted in negative social, cultural, ecological, and global effects  Urges proper adherence by all citizens to medication and appropriate drug disposal

9. International Coalition Building  Athens Declaration developed at 2 nd International Conference on the Environment  Endorses disposal options available to citizens and the 6 reasons for disposal: 1. To curtail childhood overdoses 2. To restrict household drug theft 3. To limit accumulation of drugs by the elderly 4. To protect our physical environment 5. To restrain improper international drug donations 6. To eliminate waste in the international health care systems of all countries

10. Program Overview  Unique opportunity to test and refine state- wide field model  Phased mail-in return program  Funded by the U.S. Environmental Protection Agency (EPA)  Working prototype for state and beyond  Future full scale establishment of Safe Medicine Disposal for ME

11.  Postage-paid medicine return envelopes are distributed to selected pharmacies and organizations across the state at no cost  Staff members then give the envelopes and an instruction packet to interested participants Program Model

12. Program Participants Secure delivery to Maine Drug Enforcement Agency Envelopes received, logged, catalogued and destroyed under MDEA custody

13. Program Goals  Remove unneeded prescription drugs from circulation  Disposal in compliance with applicable state and federal laws and sound environmental practices

14. Project Objectives  Calculate the weight, type and hazardous characteristics by actual pill count and drug classification  Calculate the cost of such a program  Offer an education campaign concerning proper use and disposal of prescription drugs

15. Phased Implementation  Allows for monitoring of the program and piloting of protocols  Phase I: Four-county model Pharmacies as the point of distribution for program envelopes Pharmacies as the point of distribution for program envelopes Limited press/marketing Limited press/marketing No public education effort No public education effort Selected sites within the designated area Selected sites within the designated area Only for people 65 and older and caregivers Only for people 65 and older and caregivers

16.  Geographic and demographic patterns of prescription drug accumulation  Pharmacoeconomic assessments Waste Waste Implications for prescribing, insurance reimbursement, and dispensing policies Implications for prescribing, insurance reimbursement, and dispensing policies Data Collection Strategy

17.  Full compliance for mailing USPS/State/Federal requirements USPS/State/Federal requirements  Postage-paid mailers accommodate a range of contents  Padded mailers nondescript and not easily identifiable to a criminal element The Envelopes

19. Participant Instructions

20.  Participants can use a black permanent marker to write over the name of the person who was prescribed the medicine.  They should not write over the name of the medicine or the dose. Preparing the medicine bottles

21. Up to 4 oz of liquids or creams are wrapped in a paper towel, and placed in a Ziploc bag and sealed. Liquid or cream medicine

22. Participants place sealed medicine bottles into the envelope along with the sealed Ziploc bag containing the liquid and cream medicine. When the medicine is ready…

23.  Needles or sharps cannot be returned through this program.  Participants are instructed to contact their health care provider or pharmacist for information about disposing of these items.

24.  Survey is completed and placed into the envelope with their medicine. Survey is completed

25.  Participants write down the envelope code on the corner of the medicine return envelope.  After the envelope has been mailed, participants call the program helpline at 1-866-637-9743 and leave a message with the envelope code and date it was mailed. Envelope Code Code # reporting

26.  The envelopes are mailed like any other letter or package. What happens to the envelopes

27.  The Maine Drug Enforcement Agency receives the envelopes with the medicine.  The medicine is cataloged by project pharmacists.  The participant surveys are returned to the Center on Aging for analysis. What happens to the surveys?

28.  The toll-free helpline phone number is 1-866-637-9743.  Participants can call any time and leave a message.  Phone calls are returned by Center on Aging staff.  Pharmacies or other organizations can also inquire about the program through the helpline. Program Helpline

29.  The website address is www.safemeddisposal.com  Information about the project is available on the website.  Pharmacists and project participants can also e-mail questions to the Center on Aging project staff at info@safemeddisposal.com Program Website

30.  Compliance with Maine Drug Enforcement Agency, Department of Environmental Protection Double verification of returns Double verification of returns Secure consolidation facility at an MDEA location Secure consolidation facility at an MDEA location Repeat count of number of packages received Repeat count of number of packages received Proper disposal of all drugs collected Proper disposal of all drugs collected Drug Inventory & Disposal

31. Elder Involvement  Community Advisory Board created with older adults and RSVP volunteers from each county Membership reflects state’s diversity Membership reflects state’s diversity Collaboration among 5 RSVP programs statewide Collaboration among 5 RSVP programs statewide  Community members serve as Distribution Site Educators Deliver mailers and materials to distribution sites Deliver mailers and materials to distribution sites Educate site pharmacists and staff on the process Educate site pharmacists and staff on the process  Educators promote the benefits of returning unwanted medications

32. Program Partners and National Advisory Board Maine-Based Organizations  Center on Aging, University of Maine  Maine Association of Psychiatric Physicians  Maine Benzodiazepine Study Group (MBSG) & Drug Disposal Group  Maine Council for Child & Adolescent Psychiatry  Maine Department of Health and Human Services  Maine Department of Environmental Protection  Maine Drug Enforcement Agency  Maine Office of Adult Mental Health Services  Maine Office of Substance Abuse  Maine Center for Disease Control and Prevention  Maine Office of the Attorney General  Maine Office of Elder Services  Maine Pharmacy Association  Maine Independent Pharmacies  Maine RSVP Programs  Maine Office of Adult Mental Health  Maine Medical Association  Margaret Chase Smith Center Policy Center, University of Maine  Northern New England Poison Center Federal & National Organizations  American Pharmacists Association  Community Medical Foundation for Patient Safety  National Council on Patient Information and Education  Office of the U.S. Attorney General  Rite Aid Corporation  U.S. Drug Enforcement Administration  U.S. Environmental Protection Agency  U.S. Postal Service  Villanova University Center for the Environment

33. Phase 1 Data Collection (August 2008) Points of data collection:  Survey of participants returned with drugs in the envelope

34. Phase 1 Data Collection  Cataloging of returned drugs by project pharmacists

35. Initial Phase 1 Drug Returns Data  90% of returns were prescription drugs, 10% over the counter  10% of drugs returned were controlled drugs, consistent with findings from other drug take-back events  Radiological testing confirms that there are no radioactive hazards present in the returns

36. Observations from the Initial Drug Returns Analysis (Phase 1) Interesting/anecdotal findings:  Many of the mailers contained full bottles of unused drugs from mail-order pharmacies or VA pharmacy services  Received full bottles of very costly antiretroviral drugs (HIV/AIDS drugs)-Wasted healthcare $$  Older meds not uncommon-some of the returns were noted to be as many as 7 years old  Estimated that one envelope contained enough unused narcotics to net $7,000 if sold on the street

37. Observations from the Initial Drug Returns Analysis (Phase 1) (cont.) Interesting/anecdotal findings:  A mix of local and mail order pharmacies is not uncommon among those who use the program-but who has the entire medication record for these patients? This includes patients who are receiving the same medication via a local pharmacy and a mail-order pharmacy This includes patients who are receiving the same medication via a local pharmacy and a mail-order pharmacy

38. Initial Participant Survey Data from Phase 1  Average age of program participants: 70 years old Top reasons for accumulation:  Death of a relative or loved one  Medicine expired or outdated  Doctor told patient to stop taking the medicine

39. Initial Participant Survey Data from Phase 1 (cont.)  15% of respondents did not know what kind of medicine they were returning  57% were returning medicine for themselves  53% were returning medicine for a relative.  Top reason for using the program: It’s best for the environment (83%), Safety for themselves and their families was second (8%)

40.  Phase II: The Program Goes Statewide Pharmacies as primary point of distribution for program envelopes Pharmacies as primary point of distribution for program envelopes Extensive press/marketing of the program Extensive press/marketing of the program Public education Public education Expansion of distribution beyond pharmacies Expansion of distribution beyond pharmacies Home health, Dr’s offices, social service programs, Area Agencies on AgingHome health, Dr’s offices, social service programs, Area Agencies on Aging Expansion to other age groups Expansion to other age groups Next Steps: Phase II

41.  7,200 mailers available through statewide network of participating pharmacies and partnering sites (over 100 sites)  Refinements based on Phase I experience Next Steps: Phase II

42. Want to know more about the project? Daily operations: Jennifer Crittenden, M.S.W. Project Director Research Associate UMaine Center on Aging jennifer.crittenden@umit.maine.edu Project administration: Lenard Kaye, D.S.W./Ph.D. Principal Investigator Director and Professor UMaine Center on Aging len.kaye@umit.maine.edu Technical/Scientific issues: Stevan Gressitt, M.D. Co-Principal Investigator Medical Director, Adult Mental Health Services Maine Department of Health and Human Services stevan.gressitt@maine.gov gressitt@ General Project Information: Phone: 1-866-ME-RX-RID (1-866-637-9743) Email: info@safemeddisposal.com Website: Website: http://www.safemeddisposal.com/ Maine Benzodiazepine Study Group Camden Hall 25 Texas Avenue Bangor, Maine 04401-4324 Phone: (207) 262-7920 Fax: (207) 262-7921 Email: mbsg@mainebenzo.orgmbsg@mainebenzo.org Web: http://www.mainebenzo.org/